Zhengzhou, China

Qiang Zhang

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Chinese Academy of Agricultural Sciences. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiang Zhang. Retrieved from https://idiyas.com/inventor/qiang-zhang-tk9rcbcg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 60.0

 

Average Co-Inventor Count = 9.4

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Qiang Zhang: A Innovator in Natural Active Compounds

Introduction:

Meet Qiang Zhang, a brilliant mind in the field of natural active compounds and their applications. Hailing from Zhengzhou, China, he has made considerable contributions to the scientific community through his innovative patents and research. Let's delve into his latest patents, career highlights, and collaborations to gain a deeper understanding of his remarkable accomplishments.

Latest Patents:

Qiang Zhang has successfully obtained four patents, all of which revolve around compositions containing natural active compounds with hypoglycemic properties.

1. Composition containing hesperetin and synergistic hypoglycemic application thereof:

This patent presents a composition comprising hesperetin, a flavonoid compound, and a compound X (galangin or formononetin). The mass ratio of hesperetin to galangin is 30:100, while the ratio of hesperetin to formononetin is 30:20. The composition exhibits a synergistic effect in inhibiting α-glucosidase, surpassing the effectiveness of using the flavonoid compounds alone. This innovative formula has the potential to reduce drug dosages and minimize the occurrence of drug resistance.

2. Composition for inhibiting α-glucosidase and application thereof:

In this patent, Qiang Zhang introduces a composition for inhibiting α-glucosidase, consisting of daidzein and quercetin derivatives. The quercetin derivatives include taxifolin or 3-O-methyl quercetin. The mass ratio of daidzein to taxifolin ranges from 8:25 to 10:25, whereas the mass ratio of daidzein to 3-O-methyl quercetin ranges from 8:2 to 8:4. Similar to his previous patent, this composition showcases an enhanced inhibitory effect on α-glucosidase, surpassing the activity of individual flavonoid compounds and potentially reducing drug dosage requirements.

Career Highlights:

Qiang Zhang holds a prominent position at the Zhengzhou Fruit Research Institute, which belongs to the esteemed Chinese Academy of Agricultural Sciences. As a dedicated researcher, his work focuses on the development of natural active compounds, particularly in the field of hypoglycemic applications. His patents reflect his commitment to finding innovative solutions to improve human health and reduce the burden of chronic diseases.

Collaborations:

Throughout his career, Qiang Zhang has collaborated with several esteemed researchers, fostering a culture of knowledge exchange and scientific advancement. Notable among his coworkers are Zhonggao Jiao and Jiechao Liu. Together, they have contributed to the world of natural active compounds, pooling their expertise and sharing valuable insights.

Conclusion:

Qiang Zhang's groundbreaking patents and research in the realm of natural active compounds highlight his ingenuity and dedication to developing innovative solutions in the field of hypoglycemic applications. With his contributions, he has set a remarkable example for individuals working in the intersection of science, health, and innovation. We eagerly await his future endeavors, as they continue to shape the landscape of medicinal advancements in the years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…